Document Detail


Ictus and antiphospholipid syndrome: how much is enough?
MedLine Citation:
PMID:  18324483     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Herein we report the case of a patient with antiphospholipid Syndrome (APS) and an ischemic stroke suffered while he was anticoagulated, and we discuss the usefulness of magnetic resonance angiography in the early diagnosis of such a complication. We also attempt to emphasize the great value of an individual risk evaluation when warfarin therapy is introduced. In fact, our case supports the importance of high-intensity anticoagulation in patients with multiple thrombotic recurrences, and the exceptional value that strict anticoagulation control has in this kind of patients.
Authors:
Elena Rodríguez-Castellano; Juan José Ríos-Blanco; Angel Robles-Marhuenda; Antonio Gil-Aguado; Clara Soto-Abánades; Ignacio Pérez-Valero; Arantxa Royo-Orejas; Juan José Vázquez-Rodríguez
Related Documents :
9326353 - Continuous infusion of porcine factor viii in the management of patients with factor vi...
17074733 - Language, literacy, and communication regarding medication in an anticoagulation clinic...
19166713 - Uveitis in patients with autoimmune hepatitis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Autoimmunity     Volume:  41     ISSN:  1607-842X     ISO Abbreviation:  Autoimmunity     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-03-07     Completed Date:  2008-03-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8900070     Medline TA:  Autoimmunity     Country:  England    
Other Details:
Languages:  eng     Pagination:  140-2     Citation Subset:  IM    
Affiliation:
Servicio de Medicina Interna, Hospital Universitario La Paz, P de la Castellana, 261-28046 Madrid, Spain. elena.rodriguez.c@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Anticardiolipin / blood*
Anticoagulants / administration & dosage*,  therapeutic use
Antiphospholipid Syndrome / complications*,  drug therapy
Humans
Magnetic Resonance Angiography
Male
Middle Aged
Stroke / diagnosis,  etiology*,  prevention & control
Warfarin / administration & dosage*,  therapeutic use
Chemical
Reg. No./Substance:
0/Antibodies, Anticardiolipin; 0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of AIRE in thymocytes and peripheral lymphocytes.
Next Document:  Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patie...